Seelos Therapeutics Inc (SEEL)

[Dimitrios George]

<A spokeswoman for the Irish drugmaker (WC) said the company doesn’t discuss its drug development plans publicly.>

So on the Yahoo board you have retail investors whining about issues of trust, transparency and the need for decent PR, and here we find the typical business practice of a large pharma stating that it doesn't discuss its development plans publicly. I'm with you. I like what I see in Damaj. His resume is stunning and he has delivered here.

I continue to believe that the company was running at or just below a 12-month operating reserve with no guarantee on the timing of cash infusions from deals. The last thing Damaj wants is to get squeezed for cash like his predecessor. Better to bite the bullet and buy two years worth of cash now, albeit with the pain of a drop in pps and dilution...but with the benefit of getting more institutional ownership. I may be wrong, but I am betting not.